000 01320 a2200325 4500
005 20250516115318.0
264 0 _c20130423
008 201304s 0 0 eng d
022 _a1095-8320
024 7 _a10.1016/j.biologicals.2012.09.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFeavers, Ian
245 0 0 _aWHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3-4 October 2011.
_h[electronic resource]
260 _bBiologicals : journal of the International Association of Biological Standardization
_cNov 2012
300 _a507-16 p.
_bdigital
500 _aPublication Type: Congress
650 0 4 _aGlobal Health
650 0 4 _aLicensure
650 0 4 _aMeningitis, Meningococcal
_xepidemiology
650 0 4 _aMeningococcal Vaccines
_xstandards
650 0 4 _aMolecular Epidemiology
650 0 4 _aOntario
650 0 4 _aWorld Health Organization
700 1 _aGriffiths, Elwyn
700 1 _aBaca-Estrada, Maria
700 1 _aKnezevic, Ivana
700 1 _aZhou, TieQun
773 0 _tBiologicals : journal of the International Association of Biological Standardization
_gvol. 40
_gno. 6
_gp. 507-16
856 4 0 _uhttps://doi.org/10.1016/j.biologicals.2012.09.008
_zAvailable from publisher's website
999 _c22195539
_d22195539